Clinical Trial

Assessment of the Efficacy and Safety of EESS in Patients With Incomplete Spinal Cord Injuries

Study acronym: Parastim
Recruiting
View on ClinicalTrials.gov →
Summary
Neurological disability caused by traumatic lesions of the spinal cord is a significant challenge for medicine and society. These lesions, leading to sublesional central nervous system dysfunction, include sensorimotor, vesico-sphincter and genito-sexual disorders. To date, there is no treatment that enables spinal cord function to be restored. Preclinical studies have been able to demonstrate the recovery of locomotor activity with a combination of locomotor training, pharmacological intervention and epidural electrical stimulation of the lumbosacral spinal cord (EESS) in adult rats with spinal cord transection. An American team have recently been able to show that EESS, combined with locomotor training, caused neurological improvement in four paraplegic patients, with electromyographic muscular activation patterns similar to those observed during walking. In fact, these authors also showed an improvement, under stimulation, of the VS and GS functions, but with no detailed documentation. Starting with a conceptual and preclinical rationale, and with proof of clinical concept demonstrated in several reported cases, we propose a clinical trial with an original cross-over design to validate the hypothesis that EESS combined with training in patients with incomplete spinal cord injuries would, with a good tolerance profile, allow motor, vesico-sphincter (VS) and genito-sexual (GS) disorders to be restored in patients with incomplete spinal cord injuries.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2020-07-29; most recent amendment 2026-06-09.
Status change: Not Yet Recruiting → Recruiting 2021-07-12
Trial Details
NCT Number NCT04496609
Lead Sponsor Hopital Foch
Conditions Spinal Cord Injuries
Enrollment 14 participants
Start Date 2021-07-12
Primary Completion 2028-07-12 (estimated)
Study Completion 2029-07-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-11